Brief: Spago Nanomedical Continues Recruitment In Study
March 17 (Reuters) - Spago Nanomedical AB (publ) SPAGO.ST: CONTINUES RECRUITMENT IN PHASE I/IIA TUMORAD-01 STUDY FOLLOWING POSITIVE DMC RECOMMENDATION Source text: ID:nMFN8wB6Sy Further company coverage: SPAGO.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))